Celexa and Lymphadenitis - a phase IV clinical study of FDA data

Summary:

Lymphadenitis is reported as a side effect among people who take Celexa (citalopram hydrobromide), especially for people who are male, 50-59 old, have been taking the drug for 2 - 5 years also take Aspirin, and have Bone disorder.

The phase IV clinical study analyzes which people have Lymphadenitis when taking Celexa. It is created by eHealthMe based on reports of 49,596 people who have side effects when taking Celexa from the FDA, and is updated regularly.

What is Celexa?

Celexa has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 56,390 Celexa users. Check the latest studies of Celexa.

What is Lymphadenitis?

Lymphadenitis (inflammation or enlargement of a lymph node) is found to be associated with 451 drugs and 481 conditions by eHealthMe. Check the latest studies of Lymphadenitis.

On Jul, 20, 2026

49,596 people reported to have side effects when taking Celexa.
Among them, 43 people (0.09%) have Lymphadenitis.

Among these 43 people:

How long have people been on Celexa when they have Lymphadenitis? *

What is the gender of people who have Lymphadenitis when taking Celexa? *

female: 27.91 %
male: 72.09 %

What is the age of people who have Lymphadenitis when taking Celexa? *

What are other drugs people take besides Celexa? *

What are other side effects people have besides Lymphadenitis? *

Dyspnea (difficult or laboured breathing): 33 people, 76.74%
Back Pain: 31 people, 72.09%
Heart Attack: 30 people, 69.77%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 30 people, 69.77%
Injury: 29 people, 67.44%
Pain: 28 people, 65.12%
Osteonecrosis Of Jaw (death of bone of jaw): 28 people, 65.12%
Cellulitis (infection under the skin): 27 people, 62.79%
Oedema Peripheral (superficial swelling): 26 people, 60.47%
Pneumonia: 26 people, 60.47%

What are the existing conditions these people have? *

Bone Disorder: 18 people, 41.86%
Multiple Myeloma (cancer of the plasma cells): 10 people, 23.26%
Bone Loss: 10 people, 23.26%
Osteoporosis (bones weak and more likely to break): 10 people, 23.26%
Weight Increased: 2 people, 4.65%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 2 people, 4.65%
Insomnia (sleeplessness): 2 people, 4.65%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 4.65%
Fever: 2 people, 4.65%
Birth Control: 2 people, 4.65%

* Approximation only. Some reports may have incomplete information.

Do you take Celexa and have Lymphadenitis?

- Check whether Lymphadenitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celexa:

Celexa (56,390 reports)

Lymphadenitis treatments and more:

Lymphadenitis (3,345 reports)

Browse all side effects of Celexa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Lymphadenitis:

Lymphadenitis (451 drugs)

Browse all the conditions that are associated with Lymphadenitis:

Lymphadenitis (481 conditions)

Related publications that referenced our studies

Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide (the active ingredients of Celexa) and Celexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.